When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment.
10-Dec-2013 - Puerto Rico’s drug manufacturing industry has no future unless utility costs and taxes are controlled, according to a regulatory expert.
09-Dec-2013 - Hospira says it intends to up in-house manufacture of its APIs from 10 to 50% by 2018 as it awaits completion of last year’s acquisition of Orchid.
05-Dec-2013 - A lawsuit alleging that the US FDA unlawfully detained a batch of acetaminophen API destined for CMO Gemini Pharmaceuticals could have significant impact on the drug industry's definition of an...
02-Dec-2013 - As part of its global streamlining strategy a second Irish Merck & Co plant has been earmarked to close but the firm says it remains committed to Ireland.
27-Nov-2013 - Actavis says it is restructuring a Californian manufacturing facility at a cost of 56 jobs weeks after the announced closure of a plant in North Carolina.
26-Nov-2013 - Unilife has signed a $40m long-term supply agreement with Hikma and says it is committed to becoming the world’s largest and most successful injectable drug delivery systems supplier.
25-Nov-2013 - Pfizer says it intends to shutter a manufacturing facility in Puerto Rico just days after Merck & Co. announced it was reducing its footprint on the island.
21-Nov-2013 - The high cost of energy in the UK is having a negative impact on drug and chemical firms' ability to compete according to manufacturers quizzed by the Chemical Industries Association...
19-Nov-2013 - US authorities will soon have a new system capable of tracking drugs from the factory floor to the pharmacy shelf after the Senate passed the “Drug Quality and Security Bill”...
19-Nov-2013 - An industry group has called for greater regulatory harmonization in South America, arguing that both the drug industry and patients would benefit.
18-Nov-2013 - AstraZeneca says it would never outsource the manufacture of Zoladex after announcing plans to invest £120m ($190m) in a fifth production facility for the blockbuster cancer drug.
06-Nov-2013 - Novartis has confirmed it is closing a UK facility as part of a global R&D review but remains silent on rumours specific business units will be divested.
30-Oct-2013 - API, drug intermediates and formulations firm Granules India ended the second quarter of fiscal 2013 with higher revenue and profit thanks to gains made by all three of its units.
28-Oct-2013 - Regulatory pressure for risk-based supply chain management is increasing excipient suppliers’ audit burden according to the team preparing to launch the 'excipact' certification scheme as an independent association.
23-Oct-2013 - Indian manufacturing heavyweight Mylan Laboratories is looking to build off its major acquisition of Agila with a number of smaller acquisitions, while Natco is about to receive a cash infusion...
22-Oct-2013 - Azelis says its partnership with JH Nanhang (JHNH) will feed a large demand for polyvinylpyrolidones (PVP) excipients and bring the China-made ingredients to new markets.
15-Oct-2013 - Teva says 5,000 jobs will be lost next year as it accelerates its global cost reduction programme, set to save $2bn (€1.48bn) annually by 2017.
10-Oct-2013 - Catalent has continued its softgel expansion in emerging markets with the acquisition of Relthy Laboratórios in Brazil.
09-Oct-2013 - Alchem International has commited to continue making the APIs digoxin, hyoscine hydrobromide and hyoscyamine.
08-Oct-2013 - Bliss GVS says allegations of supplying fake medicines and a blanket ban imposed on its products by the Food and Drugs Authority Ghana (FDA) is both “harsh” and “baffling.”
03-Oct-2013 - Gulf Biotech has teamed up with Merck, Helm and Linde to build a $93m (€68m) insulin facility in Bahrain.
02-Oct-2013 - Cuts intending to save Merck & Co. up to $2.5bn (€1.85bn) will not affect manufacturing until after 2015, the firm says.
26-Sep-2013 - In the wake of recent bribery scandals, Boehringer Ingelheim (B-I) has called for stricter regulations in China, as it plans to triple production at its Shanghai manufacturing site.
25-Sep-2013 - The US FDA will close its office in Amman, Jordan though the agency has been tight-lipped on the reasoning behind the decision.
23-Sep-2013 - Hikma Pharmaceuticals has signed onto a joint venture with MIDROC Pharmaceuticals to establish a presence in the Ethiopian pharmaceutical market.